← Back to Search

Apollo Wearable for Burnout

N/A
Recruiting
Led By Michelle Thompson, DO
Research Sponsored by University of Pittsburgh
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up through study completion, on average 8 weeks
Awards & highlights

Study Summary

This trial assesses how a wearable device (Apollo) can help reduce burnout in doctors by improving mood, energy, and focus.

Who is the study for?
This trial is for UPMC attending physicians and residents experiencing burnout. Participants must have an iOS or Android phone to join. Those who already own an Apollo device or are unwilling/unable to participate in the study cannot join.Check my eligibility
What is being tested?
The study is testing the Apollo Wearable, a device that emits vibrations aimed at improving mood, energy, and focus. The goal is to see if it can help reduce feelings of burnout among physicians.See study design
What are the potential side effects?
Since this trial involves a non-invasive wearable device emitting gentle vibrations, there may be minimal side effects such as discomfort from wearing the device or skin irritation.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~through study completion, on average 8 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and through study completion, on average 8 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Copenhagen Burnout Inventory
Perceived Stress Scale (PSS-10)
Secondary outcome measures
Pittsburgh Sleep Quality Index (PSQI)
The Quick Inventory of Depressive Symptomatology

Trial Design

1Treatment groups
Experimental Treatment
Group I: Apollo Intervention ArmExperimental Treatment1 Intervention
Eligible UPMC Physicians and Residents who consent to be part of this study will use an Apollo Device TVS (10-200 Hz) attached to the subject's wrist or ankle via a commercially available wearable vibration technology that can deliver TVS (Transcutaneous Vibratory Stimulation). The intensity will be targeted for the sensory threshold (the level at which the vibration is just noticeable), as this is where the TVS seems most effective from prior studies. Similar vibratory stimuli have been demonstrated to be safe in the literature. The intensity of the vibration will be adjusted to the subjects' comfort and can be controlled by the subject at any time.

Find a Location

Who is running the clinical trial?

Apollo Neuroscience, Inc.Industry Sponsor
4 Previous Clinical Trials
6,430 Total Patients Enrolled
University of PittsburghLead Sponsor
1,723 Previous Clinical Trials
16,342,856 Total Patients Enrolled
The Board of MedicineUNKNOWN
3 Previous Clinical Trials
500 Total Patients Enrolled

Media Library

Apollo Intervention Arm Clinical Trial Eligibility Overview. Trial Name: NCT05731856 — N/A
Burnout Research Study Groups: Apollo Intervention Arm
Burnout Clinical Trial 2023: Apollo Intervention Arm Highlights & Side Effects. Trial Name: NCT05731856 — N/A
Apollo Intervention Arm 2023 Treatment Timeline for Medical Study. Trial Name: NCT05731856 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there still openings for patients to join this experimental trial?

"The information on clinicaltrials.gov indicates that this particular study is not in the process of enrolling patients. It was posted initially on March 1st 2023, and its most recent update occurred February 9th 2021; however, 32 other trials are presently recruiting individuals for their research."

Answered by AI
~200 spots leftby Dec 2025